top headlines
Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]
Merck has highlighted the growing role of open-source chemistry software [...]
Movers & Shakers
sponsored content
AI and Robust Scientific Foundations to Optimize Clinical Trial Operations [...]
Saama’s Chief Customer Success and Growth Officer Ari Srinivasan speaks [...]
In this exclusive interview with Liza Laws for Discover Pharma, [...]
With 89% of AI pilots failing to scale, biopharmas can [...]
Other news
Novadip Biosciences has secured €10.4 million in convertible financing to [...]
Andelyn Biosciences is manufacturing Ultragenyx’s newly FDA-approved Fayuvi gene therapy [...]
Ariadne Bio has launched with funding from The Michael J [...]
MaaT Pharma plans to advance a global Phase 3 trial [...]
Saudi Arabia has announced more than SAR 5 billion in [...]
Skyhawk Therapeutics’ investigational oral treatment SKY-0515 showed a 1.59-point difference [...]
